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Cardiac resynchronization therapy
(CRT) in the form of biventricular pacing is
a new non-pharmacological option for a
subset of patients with advanced heart fail-
ure (HF) and ventricular conduction delay1.
The long-term studies published to date
have reported improved symptom class and
exercise duration with CRT2, and there is in-
creasing evidence that CRT may trigger an
inverse remodeling process leading to a de-
crease in ventricular volumes3. However, the
optimal identification of candidates for CRT
remains challenging. Although the QRS du-
ration was the first variable considered and
is the only parameter that has been validated
in large-scale randomized clinical trials,
QRS width is only an insensitive surrogate
marker of electromechanical delay. Acute
hemodynamic data showed an association
between QRS width and the level of the
acute hemodynamic response4, but long-
term results are lacking. Appropriate cardiac
asynchrony assessment may be achievable
through alternative methods, examined by
means of tagged magnetic resonance, ra-
dionuclide angioscintigraphy and tissue
Doppler imaging1. Such measures appear to
provide the strongest correlation with the re-
sponse to CRT, although none have yet been
proven to be optimal or broadly applicable5.
It is still important to simplify patient selec-
tion and achieve a widely acceptable para-
meter for a better stratification of patients
who are candidates for CRT.
The echocardiographic determination
of mechanical synchrony could be suffi-
cient to prospectively identify potential
CRT responders. In the InSync Italian Reg-
istry, an interventricular mechanical delay
(IVD) ≥ 45 ms was proved to be the only
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Background. There is increasing evidence that cardiac resynchronization therapy (CRT) may trig-
ger an inverse remodeling process leading to decreased left ventricular (LV) volumes in patients with
heart failure and wide QRS. However, it is still important to simplify patient selection and achieve a
widely applicable parameter to better stratify patients who are candidates for CRT.
Methods. Eighteen patients (13 males, 5 females, mean age 67.5 ± 7.2 years) with advanced heart
failure due to ischemic (n = 12) or idiopathic dilated cardiomyopathy (n = 6) and complete left bun-
dle branch block received biventricular pacing. The patients were considered eligible in the presence
of echocardiographic evidence of intra- and interventricular asynchrony, defined on the basis of LV
electromechanical delay. Investigations were performed before pacemaker implantation (at baseline),
the day after, and 3 and 6 months later.
Results. Two patients died before the first outpatient examination. There were 15 (83%) respon-
ders to reverse remodeling among the remainder. In the overall population, there was a significant
and progressive improvement in LV sphericity indexes, ejection fraction, mitral regurgitation area
and LV volumes (p < 0.001). The improvement in the interventricular mechanical delay after CRT
was significantly correlated with the decrease in LV end-systolic volume (r2 = 0.2558, p = 0.04).
Conclusions. CRT reduces LV volumes in patients with advanced heart failure, complete left bun-
dle branch block and detailed documentation of ventricular asynchrony prior to therapeutic pacing.
Broadly applicable Doppler echocardiographic measures may increase the specificity of the long-
term response to CRT in terms of LV performance.
(Ital Heart J 2004; 5 (11): 818-825)
significant prognostic indicator6. The aortic pre-ejec-
tion period may identify patients in whom reverse re-
modeling is likely and whose symptoms may improve
following CRT7. On the other hand, while CRT may
improve the contractile function only in patients with
sufficient baseline biventricular asynchrony, it may not
be sufficient to assess this parameter using the “con-
ventional” imaging modalities available to date and de-
tailed documentation of ventricular asynchrony using
more sophisticated technologies prior to therapeutic
pacing may be necessary8.
The aim of this study was to assess the effects of
long-term CRT with biventricular stimulation on the
echocardiographic surrogate parameters of reverse re-
modeling in patients with congestive HF, left bundle
branch block (LBBB) and significant electromechani-
cal delay as determined by means of broadly applicable
Doppler echocardiographic measures. 
Methods
Patient selection. The study was approved by the local
ethics committee, and all patients gave written, in-
formed consent.
All patients were recruited from our HF outpatient
clinic and were considered eligible if they were in
NYHA functional class III or IV despite optimized
drug treatment including diuretics in all patients, ACE-
inhibitors, angiotensin II receptor antagonists, beta-
blockers at the maximal tolerated dosages, and aldos-
terone antagonists. The shortest duration of HF was set
at 6 months. Patients had to be clinically stable at the
time of implantation and without any modifications of
their drug regimen for at least 1 month before enrol-
ment except some adjustments in the dose of diuretics.
Only patients with a left ventricular (LV) ejection frac-
tion ≤ 35% and LBBB were enrolled. The QRS dura-
tion had to be > 120 ms. A His-ablation performed for
atrial fibrillation < 3 months prior to enrolment was
considered an exclusion criterion. All patients were
submitted to coronary angiography to rule out any indi-
cation for revascularization. Other exclusion criteria
were unstable angina, recent revascularization (< 6
months), recent myocardial infarction (< 3 months),
and the traditional indications for pacemaker or an im-
plantable cardioverter-defibrillator.
Protocol. Investigations were performed before pace-
maker implantation (at baseline), the day after, and 3
and 6 months later. These evaluations included a 12-
lead surface electrocardiogram, Doppler echocardiog-
raphy, technical pacemaker follow-up, 6-min walk dis-
tance test, and quality of life assessment using the Min-
nesota Living With HF Questionnaire. During the study
period, medical therapy for HF was maintained un-
changed except for diuretics that were adjusted accord-
ing to clinical demands. Any changes of other medica-
tions, the need of hospitalization, and the length of hos-
pital stay were noted throughout the follow-up.
Pacemakers and leads. A permanent LV-based pace-
maker was implanted in all patients along with three
pacing leads. The LV pacing lead (one St. Jude Aescula,
St. Jude Medical, Veddesta, Sweden; two Medtronic
model 4189, Medtronic Inc., Minneapolis, MN, USA;
one 15 Guidant model 4512, Easy/track over the wire,
Guidant Inc., St. Paul, MN, USA) were positioned in the
coronary veins in accordance with the technique de-
scribed by Daubert et al.9. In the patients with atrial fib-
rillation the pacemaker was programmed in the DDDR
mode with the shortest sensed and paced atrioventricu-
lar delay set at 20 ms which corresponds to the time be-
tween left and right ventricular activation. For patients in
sinus rhythm the device was programmed to the DDD
mode with simultaneous stimulation of both ventricles.
The atrioventricular delay in patients with sinus rhythm
was individually optimized as described by Ritter10.
Two patients (10%) underwent a second procedure:
in one case, owing to coronary sinus dissection the LV
lead placement was delayed and performed successful-
ly at a second moment, and in the second patient the im-
possibility of identifying the coronary sinus necessitat-
ed a second, coronary angiography-guided procedure. 
Hospital days and hospitalizations. All-cause hospi-
talizations and the length of hospital stay during fol-
low-up were compared with the same parameters dur-
ing the same period of time for each individual patient
prior to pacemaker implantation, for a maximum of 1
year. The hospital records were reviewed by one inves-
tigator (AB) to determine the exact cause and duration
of the hospital stays. Pacemaker-related hospitaliza-
tions and the length of hospital stay following the pri-
mary implantation of the biventricular pacemaker were
monitored separately.
Echocardiographic measurements. Standard echocar-
diography, including Doppler, was performed (Agilent
Sonos 5500, Andover, MA, USA) during each of the
follow-up visits. All echocardiographic data measured
during follow-up were compared with those obtained at
baseline by one skilled operator (AB) not involved in
the clinical follow-up and blinded at all times to the
clinical data.
The LV diameters were measured during two-di-
mensional M-mode echocardiography in the short-axis
view. The LV end-diastolic diameter (LVEDD) was
measured at the onset of the QRS complex11. The lon-
gitudinal and transverse LV diameters were measured
in the apical 4-chamber view at end-diastole and end-
systole, and the sphericity index was calculated as the
LV transverse diameter/longitudinal diameter ratio12.
The biplane LV end-systolic and end-diastolic volumes
(LVESV and LVEDV, respectively) were determined
using Simpson’s equation11.
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Patients were classified as responders to reverse re-
modeling if LVESV decreased by > 15% with respect
to baseline, and as non-responders if LVESV decreased
by ≤ 15%. This classification was based on data show-
ing a variability of ≤ 15% for repeated volume calcula-
tions made using two-dimensional echocardiographic
measurements13. The diastolic function was assessed as
recommended by the American Society of Echocardio-
graphy Committee14. Mitral regurgitation (MR) was
quantified by calculating the area of the regurgitant jet
at color Doppler12.
Intraventricular and interventricular systolic echo-
cardiographic asynchrony was defined on the basis of
LV electromechanical delay (LVEMD) (i.e., the time
interval from QRS onset to the onset of aortic flow as
determined using pulsed wave Doppler) ≥ 140 ms and
of IVD (i.e., the time interval between the onset of pul-
monary ejection and aortic ejection as determined us-
ing the same technique) ≥ 40 ms, respectively. More-
over, the combined index of intraventricular and inter-
ventricular mechanical asynchronies was calculated
by adding both numbers: asynchrony = LV asyn-
chrony (LVEMD) + LV-right ventricular asynchrony
(IVD).
Since the intraobserver reproducibility of LVEMD
and IVD has been shown to be very high, a 10% varia-
tion of either of these two parameters was considered
significant15.
All M-mode, two-dimensional and Doppler mea-
surements were calculated as the average of at least
three consecutive cardiac cycles (five consecutive car-
diac cycles in patients with atrial fibrillation).
Statistical analysis. All numerical data are expressed as
mean ± SD unless otherwise specified. Within group
comparisons were made using the one-way ANOVA test
for repeated measures or paired Student’s t-tests with
the Bonferroni correction for multiple comparisons.
Univariate linear regression analysis was used to corre-
late the decrease in the electromechanical delay with the
long-term improvement in LV volumes. In addition, lin-
ear regression analysis was used for the evaluation of
changes in the MR area, LV volumes, and sphericity in-
dexes. The Wilcoxon signed rank test was used to com-
pare all-cause hospitalization and the length of hospital
stay before implantation and during follow-up.
A two-tailed p value < 0.05 was considered as sta-
tistically significant.
Results
Patient characteristics. Between November 2001 and
April 2003, 18 patients were enrolled in the study after
obtaining informed consent and following the successful
implantation of a biventricular pacemaker. No patient
was lost to follow-up. The mean duration of HF before
inclusion in the study was 40.5 ± 25 months. Table I il-
lustrates the baseline data of our patient population. Of
the 12 patients with ischemic heart disease, 7 had previ-
ous myocardial infarction and 4 had undergone coronary
artery bypass surgery. Apart from 6 patients with atrial
fibrillation who had previously been submitted to ra-
diofrequency ablation of the atrioventricular node, none
had a conventional indication for pacing. Thirteen pa-
tients were on treatment with ACE-inhibitors or an-
giotensin II receptor blockers (for enalapril the mean
dose was 20.0 ± 5 mg); 10 patients were on beta-block-
ers (the mean dose of carvedilol was 12.5 ± 0.5 mg), and
11 on aldosterone antagonists. The mean dose of
furosemide was 52.2 ± 20.2 mg. Two patients died of
progressive HF before the first outpatient examination
(22 and 46 days after biventricular pacemaker implanta-
tion). Their baseline characteristics were comparable to
those of the remaining study group. All the remaining 16
patients completed 6 months of follow-up.
Pacemaker implantation. The mean operative time
was 65.4 ± 28.2 min and the mean fluoroscopy time
33.6 ± 21.3 min. The mean length of hospital stay for
pacemaker implantation was 2.3 ± 0.7 days. Follow-up
evaluation revealed stable LV stimulation thresholds
over time. The LV lead threshold increased in 2 cases
that were treated via telemetry.
Reverse remodeling. Data regarding reverse remodel-
ing are summarized in table II. LVESV and LVEDV de-
creased early after pacing (p < 0.0001) and improved
further during follow-up (p < 0.0001 at 3 months, p
< 0.0001 at 6 months). LVEDD was also significantly
decreased 3 and 6 months after pacing therapy (p
< 0.0001, p < 0.0001 respectively).
At 6 months 15 of 16 survivors (83%) were consid-
ered as responders to reverse remodeling with a > 15%
decrease in LVESV compared to baseline. The average
decrease in LVESV at 6 months was 28.6 ± 8.7% while
the average decrease in LVEDV was 18.3 ± 7.2%. The
sphericity indexes, both the end-systolic and end-dias-
tolic, increased early after pacemaker implantation fur-
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Table I. Baseline clinical characteristics.
No. patients 18
Age (years) 67.5 ± 7.2
Male gender 13 (72%)
Body mass index (kg/m2) 25 ± 4.0
Ischemic etiology 12 (67%)
NYHA class III 14 (77%)
NYHA class IV 4 (22%)
Left ventricular ejection fraction (%) 23.2 ± 5.7
Baseline QRS length (ms) 157.9 ± 14.4
Atrial fibrillation 6 (33%)
Concomitant therapy (%)
ACE-inhibitors 61
AT1 receptor antagonists 11
Beta-blockers 55
Aldosterone antagonists 61
ther improving after 3 and 6 months (all p < 0.0001).
The mean ejection fraction and mean MR area im-
proved in survivors (p < 0.001). With regard to diastole,
the deceleration time increased significantly at follow-
up (p < 0.003). The duration of the QRS complex de-
creased significantly from 157.9 ± 14.4 ms at baseline
to 134.5 ± 9.0 ms during pacing (p < 0.0001). In the 11
patients who were followed up until 12 months a fur-
ther improvement in the echocardiographic indices of
reverse remodeling (mean decrease in LVESV 35.8 ±
12.6%, mean decrease in LVEDV 20.2 ± 7.6%, p
< 0.0001) was observed. 
Clinical assessment. The main features are depicted in
table III. The NYHA functional class improved by at
least one class in all surviving patients. At follow-up
CRT progressively improved the quality of life score (p
< 0.001) and the 6-min walk distance test (p < 0.001).
The systolic and diastolic blood pressure, resting heart
rate and body weight at baseline and during follow-up
were similar.
Asynchrony patterns. The baseline and follow-up
asynchrony patterns are depicted in table III. CRT in-
duced interventricular resynchronization, as shown by
a significant reduction of the systolic IVD (p < 0.001)
and LVEMD (p < 0.001) during follow-up.
Hospital days and hospitalizations. There was a sig-
nificant reduction in the frequency and duration of hos-
pitalization (Table IV).
Predictors of long-term efficacy. Regression analysis
of the asynchrony patterns and the echocardiographic
outcome showed a significant positive linear correla-
tion between IVD ( = baseline – the day after CRT
absolute differences) and the decrease in LVESV (r2 =
0.26, p = 0.04) (Fig. 1) and MR (r2 = 0.33, p = 0.01) at
follow-up, and an inverse correlation between IVD
and the increase in the systolic sphericity index at fol-
low-up (r2 = 0.30, p = 0.02). On the contrary, we did not
observe any correlation between baseline IVD,
LVEMD or QRS width and the echocardiographic
outcome. No associations were found between the QRS
A Barbieri et al - Biventricular pacing and reverse remodeling
821
Table II. Echocardiographic indices of left ventricular remodeling.
Variables Baseline After CRT 3 months 6 months p
(n=18) (n=16) (n=16) (n=16)
LVEF (%) 23.2 ± 5.7 27.9 ± 5.9 33.5 ± 7.9 34.4 ± 4.4* < 0.001
LVEDV (ml) 321.1 ± 30.0 301.9 ± 32.0 275.7 ± 34.0 258.1 ± 32.7 < 0.001
LVESV (ml) 256.4 ± 25.8 234.2 ± 26.4 201.9 ± 36.4 179.4 ± 30.2 < 0.001
LVEDD (mm) 84.1 ± 6.1 81.3 ± 5.9 75.9 ± 5.6 69.8 ± 6.0 < 0.001
MR (cm2) 8.6 ± 4.1 6.5 ± 3.8 4.9 ± 3.6 3.4 ± 3.2** < 0.001
E/A ratio 1.2 ± 0.8 1.1 ± 0.7 0.8 ± 0.6 0.7 ± 0.6 < 0.001
Diastolic SI 1.14 ± 0.05 1.23 ± 0.06 1.29 ± 0.06 1.38 ± 0.07 < 0.001
Systolic SI 1.27 ± 0.08 1.32 ± 0.08 1.47 ± 0.09 1.48 ± 0.103§ < 0.001
Heart rate (b/min) 70 ± 12 69 ± 12 67 ± 12 66 ± 11 NS
CRT = cardiac resynchronization therapy; LVEDD = left ventricular end-diastolic diameter; LVEDV = left ventricular end-diastolic vol-
ume; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; MR = area of mitral regurgitation; SI =
sphericity index. All comparisons within subjects were found to be significant with p < 0.0001, apart from * p = 0.08 vs 3 months, **
p = NS vs 3 months, § p = 0.01 vs 3 months.
Table III. Functional and echocardiographic asynchrony parameters.
Baseline After CRT 3 months 6 months p
(n=18) (n=16) (n=16) (n=16)
Quality of life 60.4 ± 14 52.7 ± 13§ 48.2 ± 15 30.6 ± 11 < 0.001
6MWD (m) 367.7 ± 94 401.0 ± 82 416.6 ± 73* 503.6 ± 64 < 0.001
LVEMD 164.9 ± 23.0 160.0 ± 21.0 150.4 ± 19.7** 149.9 ± 19.8§§ < 0.001
IVD 58.7 ± 11.7 43.5 ± 8.2 34.5 ± 5.8 27.4 ± 4.0§§§ < 0.001
CRT = cardiac resynchronization therapy; IVD = interventricular mechanical delay; LVEMD = left ventricular electromechanical de-
lay; 6MWD = 6-min walk distance. All comparisons within subjects were found to be significant with p < 0.0001, apart from * p = 0.017
vs after CRT, ** p = 0.001 vs after CRT, § p = 0.006 vs baseline, §§ p = NS vs 3 months, §§§ p = 0.01 vs 3 months.
Table IV. Hospitalizations during the 6 months before and the 6
months after biventricular pacing implantation.
Variables 6 months before 6 months after p
(n=16) (n=16)
No. hospitalizations 1.5 (1-2) 0 (0-1) 0.008
Hospital stay (days) 8 (3-21) 0 (0-3) 0.060
Data are expressed as median and first and third quartile.
reduction after CRT and the echocardiographic indices
of LV remodeling and the baseline measures of asyn-
chrony. Moreover, no associations were found between
the combined index of asynchrony and the variation in
LVESV after CRT (r2 = 0.009, p = 0.22).
The percentage LVESV decrease was inversely cor-
related with the diastolic sphericity index (r2 = 0.59, p =
0.025). Improvement in MR area was slightly correlated
with the systolic sphericity index (r2 = 0.52, p = 0.058).
Reproducibility. In 6 study patients and 4 non-study
subjects with LBBB and a QRS duration > 120 ms, the
intraobserver variability was 7.8% for the measurement
of LV ejection fraction, 4.4% for LVEDD, 8.6% for
LVEDV, 9.1% for LVESV, 3.0% for IVD, and 4.0% for
LVEMD.
Discussion
The main finding of our study is that CRT in the
form of biventricular pacing provides a significant clin-
ical and functional benefit in patients with complete
LBBB (QRS ≥ 120 ms) and dilated cardiomyopathy of
various etiologies, selected on the basis of simple and
broadly applicable measures of interventricular and in-
traventricular asynchrony.
Previous studies have suggested, on the basis of the
QRS duration, that despite careful patient selection,
some did not respond to CRT2. In addition, many
chronic studies have shown that the QRS duration is a
poor predictor of the clinical CRT response, assessed
largely by echo-Doppler-derived objective measures of
chamber function or reverse remodeling13,15-19 rather
than by clinical symptoms.
In our observational series, we used imaging modal-
ities to detect baseline evidence of systolic asynchrony
in an effort to increase the specificity of the long-term
response to CRT in terms of LV performance. We found
a short-term effect of CRT on the systolic function, MR
area, and LV volumes. However, the gain was even
greater in the long-term (6 months), when the improve-
ment was also confirmed by a reversal of LV remodel-
ing, a major phenotypic component of the pathophysi-
ologic mechanisms of HF20.
It has been suggested that these long-term effects
are similar in magnitude to the acute changes observed
after 1 month of CRT21, hypothesizing that Doppler
echocardiography early after device implantation may
predict a beneficial long-term response22. However, re-
synchronization is only one of the improvement mech-
anisms of CRT. Recently, in a randomized controlled
study St. John Sutton et al.23 have shown a reverse re-
modeling effect of CRT and confirmed earlier reports
from smaller trials13,15-19. This chronic effect of CRT
might be the result of an unloading process secondary
to the decrease in mitral valve regurgitation, sympa-
thetic/parasympathetic balance and the reduction in the
total work performed by the late activated region3,
combined with progressive normalization, at a cellular
level, in the concentrations of stress-sensitive kinases
and calcium handling proteins24.
Stellbrink et al.13 evaluated non-responders to LV
reverse remodeling after CRT using a cut-off > 15% for
the decrease in LVESV; a lack of response was present
in 9 out of 25 patients (36%). Yu et al.19 found that 43%
of their patients were volumetric non-responders.
These included those patients (13%) who presented
with a further increase in LVESV > 10%. Direct as-
sessment of systolic asynchrony by noninvasive
echocardiography was the only independent predictor
of reverse remodeling. Unfortunately, these baseline
parameters were identified only retrospectively.
In the present study, 15 of 18 patients (83%) were
classified as long-term volumetric responders to CRT.
At 28.6 ± 8.7%, the degree of improvement corre-
sponds with that found in previous studies reporting a
decreased LVESV at 6 months and is substantially
greater than that achieved with pharmacological inter-
vention alone20. LV reverse remodeling occurred in
parallel with the improvement in symptoms, quality of
life, and exercise tolerance. There was a strong trend to-
ward a decreased hospitalization, as one would expect
from a therapy that improves symptoms without major
adverse effects.
Several studies have reported improved quality of
life and functional parameters after CRT2. However,
clinical endpoints are limited by the subjective nature
of the patients’ own evaluation (especially NYHA class
and quality-of-life score). Besides, placebo effects may
also contribute to the perceived improvement. Caution
is warranted, however, when interpreting parameters of
remodeling measured by those surrogates that do not
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Figure 1. The regression line shows a fairly good correlation between
the magnitude of the interventricular mechanical delay (IVD) decrease
(baseline – the day after cardiac resynchronization therapy absolute dif-
ferences) and the magnitude of the left ventricular end-systolic volume
(LVESV) decrease (follow-up – baseline absolute differences) (p =
0.046, r2 = 0.2558).
carry intrinsic value for survival or function, particular-
ly with a novel type of therapy25. In the Multicenter In-
Sync Randomized Clinical Evaluation (MIRACLE) tri-
al, determination of the LV size and function was found
to correlate only weakly with the clinical improvement
and exercise capacity, although both measurements are
predictive of the clinical outcome23.
A dose-related “reverse remodeling effect” in HF
has been described for beta-blocker treatment20. In our
study, an addictive effect of beta-blockers on LV vol-
umes cannot be completely ruled out. Since CRT may
modify other aspects of the management of the patient,
as would occur in clinical practice, it should be consid-
ered as a therapeutic strategy complementary to beta-
blocker treatment rather than simply a device. Howev-
er, the patients were receiving stable drug therapy be-
fore enrolment, and only minor dose adjustments were
implemented during the study.
Importantly, in our study no relation was found be-
tween the extent of baseline intraventricular asyn-
chrony and the magnitude of LV reverse remodeling.
This is apparently in contrast with the results of the
main studies on this topic. However, when LVEMD
was investigated as a surrogate of global electro-
mechanical coupling, our data were found to be similar
to those of Pitzalis et al.15. Mechanical asynchrony, as
assessed using echo-markers alone, may not be suffi-
ciently precise to disclose the presence of this correla-
tion. In fact, this technique does not allow simultaneous
comparison of the regional timing in different cardiac
segments during one beat. As described by Sogaard et
al.18, patients with greater systolic asynchrony (respon-
ders) have a significant amount of myocardium that ex-
hibits post-systolic shortening, but the amount of my-
ocardium with delayed contraction cannot be evaluated
using conventional Doppler indices. However, what de-
gree of mechanical asynchrony should be treated and
what abnormalities may be reversible are still subjects
of debate. In contrast, tissue Doppler imaging was
demonstrated to be a better predictor of the improve-
ment in LVEF and of the decrease in LV volumes after
CRT than the QRS duration26,27. Other authors high-
lighted the potential of tissue Doppler imaging in the
evaluation of the regional LV delay and its implications
in the selection of the pacing site, as greater improve-
ments in LVESV and ejection fraction were observed in
patients paced specifically at sites of greatest contrac-
tion delay28.
In the present study, the magnitude of improvement
in the interventricular synchrony after CRT correlated
significantly with the improvements in echocardio-
graphic outcome. This is in accordance with what ob-
served in previous studies performed with Doppler
echocardiography16,29 or nuclear phase imaging30.
These data suggest that interventricular asynchrony is a
correctable parameter contributing to LV dysfunction.
Although interventricular asynchrony did not prove to
be of prognostic importance in idiopathic dilated car-
diomyopathy31, its correction may all the same consti-
tute a therapeutic target and may still lead to hemody-
namic improvement32.
The results from this study show that pacing thera-
py is effective mainly in the reduction of IVD rather
than of LVEMD. Our population was heterogeneous,
including many patients with ischemic heart disease
(67%) and previous myocardial infarction (38%). My-
ocardial scarring has a significant impact on LV syn-
chronization even in the absence of bundle branch
block. This is especially true in case of an anterior my-
ocardial infarction33. The larger the myocardial infarct
area, the more severe the LV asynchrony and the lower
the probability that it reverses after CRT. Biventricular
pacing, although changing the orientation of the activa-
tion/contraction wave-front, may not be sufficient to
overcome the conduction delay related to a fixed scar in
the myopathic ventricle. Moreover, biventricular pac-
ing may improve LV synchronicity by shortening the
total isovolumic time17 or by redistributing the longitu-
dinal myocardial deformation, indicating a more ener-
gy-efficient contraction34. Sogaard et al.18 have pointed
out that after CRT the improvement in systolic function
appeared to be confined to the base of the left ventricle,
whereas the mid-ventricular and apical areas of the
ventricle did not seem to be resynchronized. These da-
ta stress the concept that left intraventricular asyn-
chrony may still persist after biventricular pacing,
notwithstanding right and left interventricular resyn-
chronization.
Finally, in our series 2 patients died of progressive
HF. In these patients, right ventricular HF was more
pronounced than LV failure. Overriding comorbidities
may attenuate the response to CRT and the long-term
impact of CRT on hospitalization and mortality28.
However, questions remain as to whether CRT stimu-
lation is needed, whether multisite left-heart stimula-
tion would enhance its efficacy and as to which is the
best time delay between right ventricular and LV stim-
ulation8.
Study limitations. The main limitation of this study is
the lack of a control group; i.e., patients with HF and
LBBB but no echocardiographic asynchrony at base-
line.
The site of LV pacing and the tailored sequential
CRT were not individually optimized, but to date there
is no agreement on how this is best accomplished.
However, we selected patients with complete LBBB in
whom it is mainly the lateral LV wall which is activat-
ed last35.
Due to the small sample size, this study is not suffi-
ciently powered to identify the baseline predictors of
positive ventricular remodeling. The small number of
non-responders does not justify a more extensive analy-
sis, in particular of LV predictors, by means of univari-
ate and multivariate models. However, in previous re-
ports19,26 the patient and disease characteristics were
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not found to be predictive of the LV volumetric
changes, highlighting the limitations of selecting pa-
tients on the basis of their clinical characteristics.
Six patients (33%) were in chronic atrial fibrillation
and had been previously subjected to radiofrequency
ablation of the atrioventricular node. This must be tak-
en into consideration when interpreting results because
the heart rate control benefit probably adds up to that of
ventricular resynchronization. All the same, in acute
and chronic hemodynamic studies the benefit was ob-
served for both patients in sinus rhythm as well as for
those with atrial fibrillation, stressing the importance of
ventricular resynchronization, regardless of the atrio-
ventricular synchrony36.
Finally, the cardiac asynchrony was evaluated using
a rather simple and non-sophisticated Doppler mea-
surement. As previously suggested29, we should expect
even better clinical outcomes in the event of patients
being selected with more sophisticated imaging tech-
niques, but it is still important to simplify the selection
process in candidates for CRT using widely acceptable
parameters5.
In conclusion, this study suggests that CRT in pa-
tients with stable severe HF (in spite of optimal thera-
py), LBBB and detailed documentation of ventricular
asynchrony prior to therapeutic pacing is a useful clin-
ical strategy, with benefit persisting for more than a few
months. Whether reverse remodeling induced by CRT
will improve the patient outcome, as observed with
pharmacological therapy, needs to be addressed by
large-scale, multicenter studies.
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